In order to understand how monoallelic or biallelic BIRC3 loss contributes to the pathobiology of del(11q) CLL, we used the CRISPR/Cas9-editing technology to model these alterations in an in vitro system. The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.